Xarelto, generically known as rivaroxban, is an oral anticoagulant drug manufactured by Bayer. Anticoagulants are a class of drugs used to prevent blood clotting, and can be used to treat a variety of conditions. Xarelto was first approved by the Federal Food and Drug Administration to treat people with an irregular heartbeat known as atrial fibrillation,and has since been approved to treat and prevent conditions such as deep vein thrombosis and pulmonary embolism.
Recent studies have indicated that people who use Xarelto may be at risk of developing serious complications such as internal or uncontrollable bleeding, which may become life threatening. Symptoms of internal bleeding can include:
Concerns have been raised regarding the safety data Bayer provided to the FDA and other regulators. Moreover, questions have surfaced about the amount and quality of safety data that Bayer has provided to the FDA and other regulators.
Xarelto is a relatively new drug, and regulatory agencies have not yet collected enough data to determine whether the drug poses a significant risk to consumers. The preliminary data seems to suggest that there may be undisclosed risks associated with Xarelto, and people who have suffered an adverse event may be able to recover for their injuries. In order to determine whether you have a claim, you should contact an experienced Xarelto lawyer.
For assistance with your Xarelto case, click here to find Xarelto lawyers near you or find lawyers in a different state.